3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
13
cyclopia sequence
7
Neoplasms
5
Polycystic Ovary Syndrome
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Lung Neoplasms
3
Leiomyoma
3
Head and Neck Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Vomiting
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Obesity
2
Neoplasms, Plasma Cell
2
Nausea
2
Hematologic Diseases
2
Fatigue
2
Depression
2
Weight Loss
1
Warts
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Sleepiness
1
Sezary Syndrome
1
Prostatic Intraepithelial Neoplasia
1
Primary Myelofibrosis
1
Peripheral Nervous System Diseases
1
Pediatric Crohn's disease
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Interventions
rozanolixizumab
5
zilucoplan
4
eculizumab
4
efgartigimod alfa
3
Rituximab
2
Prednisone
2
Amifampridine
2
thymoglobulin
1
satralizumab
1
rhoA GTP-Binding Protein
1
ravulizumab
1
iscalimab
1
inebilizumab
1
gamma-Globulins
1
Thymectomy
1
Sugars
1
Steroids
1
Sodium Chloride
1
Robotic Surgical Procedures
1
Prednisolone
1
Methylprednisolone
1
Methotrexate
1
Mesna
1
Hizentra
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Fluid Therapy
1
Cyclophosphamide
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Myasthenia Gravis
×
Sugars
×
Clear all
NCT00995722
2017-06-02
EPITOME'
University of Miami
Phase 3
Terminated
11 enrolled
14 charts